TIDMEVG

RNS Number : 7510J

Evgen Pharma PLC

14 December 2022

Evgen Pharma plc

("Evgen" or the "Company")

Grant of Options

Evgen Pharma plc (AIM: EVG), a clinical stage drug development company developing sulforaphane-based medicines announces that , on 14 December 2022, certain employees and directors of the Company, including the following Persons Discharging Managerial Responsibility ("PDMR"), were granted nil cost options (the "Options") over a total of 11,122,199 ordinary shares of 0.25 pence each in the Company ("Ordinary Shares"), exercisable, subject to the Options vesting, for a period of up to 10 years from the date of grant and governed by the rules of the Evgen Pharma plc Long Term Incentive Plan ("LTIP").

 
 PDMR                Position       Current Ordinary  Current Options held   New options granted     % of issued share 
                                         Shares held                                                 capital including 
                                                                                                            this award 
                                                                            -------------------- 
 Dr Huw Jones       CEO                       62,500             4,648,890   4,410,727                            3.3% 
                   ----------  ---------------------  --------------------  -------------------- 
 Richard Moulson    CFO                       45,454               889,728   1,460,855                            0.9% 
                   ----------  ---------------------  --------------------  -------------------- 
 

The Options will vest on the third anniversary of grant based on performance against challenging

strategic corporate objectives over three years (40%), share price growth (30%) and on an elapsed time basis at 3 years (30%).

Following this award there are 21,361,574 options in issue, representing 7.8% of the Company's issued share capital.

Enquiries:

 
 Evgen Pharma plc 
  Dr Huw Jones, CEO 
  Richard Moulson, CFO                         +44 1625 466591 
 FinnCap (Nominated Advisor and 
  Broker) 
  Geoff Nash / Teddy Whiley (Corporate 
  Finance) 
  Alice Lane/Nigel Birks (ECM)                +44 20 7220 0500 
 Instinctif Partners                          +44 207 457 2020 
  Melanie Toyne-Sewell / Rozi Morris       Evgen@Instinctif.co 
  / Agnes Stephens / Adam Loudon 
 

The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 
 1     Details of the person discharging managerial responsibilities/person closely associated 
 a)    Name                                                         Huw Jones 
      -----------------------------------------------------------  --------------------------------------------------- 
 2     Reason for the notification 
      ---------------------------------------------------------------------------------------------------------------- 
 a)    Position/status                                              CEO 
      -----------------------------------------------------------  --------------------------------------------------- 
 b)    Initial notification /Amendment                              Initial Notification 
      -----------------------------------------------------------  --------------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, auction platform, auctioneer 
        or auction monitor 
      ---------------------------------------------------------------------------------------------------------------- 
 a)    Name                                                         Evgen Pharma Plc 
      -----------------------------------------------------------  --------------------------------------------------- 
 b)    Legal Entity Identifier                                      213800NO3E6TSTQO8K20 
      -----------------------------------------------------------  --------------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
        each type of transaction; (iii) each date; and (iv) each place where transactions have been 
        conducted 
      ---------------------------------------------------------------------------------------------------------------- 
 a)    Description of the financial instrument, type of             Options over Ordinary Shares of 0.25 pence each 
       instrument                                                    GB00BSVYN304 
 
       Identification code 
      -----------------------------------------------------------  --------------------------------------------------- 
 b)    Nature of the transaction                                    Grant of options 
      -----------------------------------------------------------  --------------------------------------------------- 
 c)    Currency                                                     GBP 
      -----------------------------------------------------------  --------------------------------------------------- 
 d)    Price(s) and volume(s)                                       Price(s)                   Volume(s) 
      -----------------------------------------------------------  -------------------------  ------------------------ 
   nil                                                                                         4410727 
  ------------------------------------------------------------------------------------------  ------------------------ 
 
 e)    Aggregated information 
        - Aggregated volume                                           As above 
        - Price 
        - Aggregated total 
      -----------------------------------------------------------  --------------------------------------------------- 
 f)    Date of the transaction                                      14 December 2022 
      -----------------------------------------------------------  --------------------------------------------------- 
 g)    Place of the transaction                                     London Stock Exchange, AIM 
      -----------------------------------------------------------  --------------------------------------------------- 
 
 
 1     Details of the person discharging managerial responsibilities/person closely associated 
 a)    Name                                                         Richard Moulson 
      -----------------------------------------------------------  --------------------------------------------------- 
 2     Reason for the notification 
      ---------------------------------------------------------------------------------------------------------------- 
 a)    Position/status                                              CFO 
      -----------------------------------------------------------  --------------------------------------------------- 
 b)    Initial notification /Amendment                              Initial Notification 
      -----------------------------------------------------------  --------------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, auction platform, auctioneer 
        or auction monitor 
      ---------------------------------------------------------------------------------------------------------------- 
 a)    Name                                                         Evgen Pharma Plc 
      -----------------------------------------------------------  --------------------------------------------------- 
 b)    Legal Entity Identifier                                      213800NO3E6TSTQO8K20 
      -----------------------------------------------------------  --------------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
        each type of transaction; (iii) each date; and (iv) each place where transactions have been 
        conducted 
      ---------------------------------------------------------------------------------------------------------------- 
 a)    Description of the financial instrument, type of             Options over Ordinary Shares of 0.25 pence each 
       instrument                                                    GB00BSVYN304 
 
       Identification code 
      -----------------------------------------------------------  --------------------------------------------------- 
 b)    Nature of the transaction                                    Grant of options 
      -----------------------------------------------------------  --------------------------------------------------- 
 c)    Currency                                                     GBP 
      -----------------------------------------------------------  --------------------------------------------------- 
 d)    Price(s) and volume(s)                                       Price(s)                   Volume(s) 
      -----------------------------------------------------------  -------------------------  ------------------------ 
   nil                                                                                         1460855 
  ------------------------------------------------------------------------------------------  ------------------------ 
 
 e)    Aggregated information 
        - Aggregated volume                                           As above 
        - Price 
        - Aggregated total 
      -----------------------------------------------------------  --------------------------------------------------- 
 f)    Date of the transaction                                      14 December 2022 
      -----------------------------------------------------------  --------------------------------------------------- 
 g)    Place of the transaction                                     London Stock Exchange, AIM 
      -----------------------------------------------------------  --------------------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHUSRBRUSUUAAA

(END) Dow Jones Newswires

December 14, 2022 12:08 ET (17:08 GMT)

Evgen Pharma (LSE:EVG)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024 Haga Click aquí para más Gráficas Evgen Pharma.
Evgen Pharma (LSE:EVG)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024 Haga Click aquí para más Gráficas Evgen Pharma.